Biotech

All Articles

Ultragenyx fine-tunes genetics treatment application to dial up efficacy

.A minority of patients taking Ultragenyx Drug's Wilson disease gene treatment UX701 have come off s...

Biopharma unemployment rate maintains in Q3: Ferocious Biotech evaluation

.As summertime heat energy turns to cool down winds, wishes that this year will carry wide-spread fi...

J &amp J goes down period 2 dengue candidate in most recent switch from injections

.Johnson &amp Johnson's deprioritization of its infectious ailment pipe has actually asserted yet an...

Relay loses 10% of staff after earlier cutbacks in July

.Precision medication biotech Relay Therapies is dropping around 10% of its own labor force in initi...

Pentixapharm scores $22M IPO to advance radiopharma trials

.Pentixapharm has introduced virtually 20 million euros ($ 22 thousand) coming from an IPO, along wi...

Lundbeck faucets Charles Waterway for AI-enabled neuro medicine breakthrough

.Lundbeck has actually tapped Charles Waterway Laboratories' expert system abilities to aid the disc...

Big pharma, biotech 'won't necessarily be symbiotic' in AI: S&ampP

.Huge Pharma is spending greatly in artificial intelligence to lower development timetables as well ...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Biography has actually roped in $115 thousand in series B funds to accelerate preclinical a...

IGM rotates from cancer to autoimmune, shocking C-suite

.IGM Biosciences ended in 2014 giving up workers and also improving its cancer cells pipeline. Right...

Shattuck centers CD47 program over unstable efficacy information, lays off 40% of staff and also sheds Ono deal

.Shattuck Labs has knocked yet another nail right into the coffin of CD47. After viewing a "moderate...